Nguyen, D., Jabbour, E., Kantarjian, H. M., Macaron, W., Jain, N., Nasnas, C., Kebriaei, P., Shpall, E. J., Khouri, I., Haddad, F., Karrar, O., Maroun, M., Garris, R., Ravandi, F. and Short, N. J. (2026) “Impact of high-sensitivity next-generation sequencing measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRDpositive B-cell acute lymphoblastic leukemia”, Haematologica. Pavia, Italy, 111(11), pp. 3785-3789. doi: 10.3324/haematol.2025.289318.